LAURA BELL: Open Payments
NPI 1245894658 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,488 in 186 payments from 36 companies in 2025. Trend: 2023 $2,808 · 2024 $3,840 · 2025 $3,488
Food & beverage: $3,488
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $683 |
| PFIZER INC. | 43 | $439 |
| Axsome Therapeutics, Inc. | 8 | $253 |
| JAZZ PHARMACEUTICALS INC. | 9 | $217 |
| Novartis Pharmaceuticals Corporation | 13 | $170 |
| Recor Medical Inc | 1 | $145 |
| ARGENX US, INC. | 5 | $133 |
| Lundbeck LLC | 5 | $120 |
| Lilly USA, LLC | 6 | $112 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $84 |
Products named: QULIPTA, NURTEC ODT, XYWAV, KESIMPTA, Symbravo, Paradise Ultrasound Renal Denervation System, VYALEV, VYEPTI.
Industry payments across FL — which companies pay providers there.
